ストックスクリーナーアプリを入手
311.92
5.86%
17.27
アフターアワーズ：
311.92
前日終値:
$294.65
開ける：
$296.81
24時間の取引高:
352.74K
Relative Volume:
0.70
時価総額：
$8.69B
収益：
$7.46M
当期純損益:
$-303.27M
株価収益率:
-23.16
EPS:
-13.4668
ネットキャッシュフロー:
$-249.12M
1週間 パフォーマンス:
+8.01%
1か月 パフォーマンス:
-10.25%
6か月 パフォーマンス:
+533.34%
1年 パフォーマンス:
+769.83%
1日の値動き範囲:
$296.81
$314.00
1週間の範囲:
$285.00
$314.00
52週間の値動き範囲:
$26.70
$356.00
Praxis Precision Medicines Inc Stock (PRAX) Company Profile
名前
Praxis Precision Medicines Inc
セクター
電話
617-300-8460
住所
99 HIGH STREET, 30TH FLOOR, BOSTON
Compare PRAX vs VRTX, REGN, ALNY, ARGX, INSM
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
PRAX
Praxis Precision Medicines Inc
|
311.92 | 8.21B | 7.46M | -303.27M | -249.12M | -13.47 |
VRTX
Vertex Pharmaceuticals Inc
|
454.97 | 113.96B | 12.07B | 3.95B | 3.19B | 15.33 |
REGN
Regeneron Pharmaceuticals Inc
|
749.47 | 78.41B | 14.34B | 4.50B | 3.77B | 41.56 |
ALNY
Alnylam Pharmaceuticals Inc
|
328.70 | 40.85B | 3.71B | 313.75M | 465.38M | 2.2571 |
ARGX
Argen X Se Adr
|
697.05 | 42.05B | 4.16B | 1.29B | 734.26M | 19.58 |
INSM
Insmed Inc
|
148.31 | 29.99B | 606.42M | -1.28B | -997.58M | -6.403 |
Praxis Precision Medicines Inc Stock (PRAX) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2026-02-24 | 開始されました | Wolfe Research | Outperform |
| 2026-02-02 | 開始されました | Wells Fargo | Equal Weight |
| 2025-12-15 | 繰り返されました | Oppenheimer | Outperform |
| 2025-11-19 | 開始されました | BTIG Research | Buy |
| 2025-06-02 | 再開されました | Oppenheimer | Outperform |
| 2025-05-07 | 開始されました | Chardan Capital Markets | Buy |
| 2025-03-03 | 繰り返されました | H.C. Wainwright | Buy |
| 2025-02-11 | 開始されました | Deutsche Bank | Buy |
| 2024-08-05 | 開始されました | Oppenheimer | Outperform |
| 2024-06-24 | 開始されました | Needham | Buy |
| 2024-06-18 | 開始されました | Guggenheim | Buy |
| 2024-05-01 | 開始されました | Robert W. Baird | Outperform |
| 2023-09-19 | 開始されました | Truist | Buy |
| 2022-06-06 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-12-16 | 開始されました | H.C. Wainwright | Buy |
| 2021-08-26 | 開始されました | BofA Securities | Buy |
| 2021-04-26 | 開始されました | William Blair | Outperform |
| 2020-11-11 | 開始されました | Wedbush | Outperform |
| 2020-11-10 | 開始されました | Cowen | Outperform |
| 2020-11-10 | 開始されました | Evercore ISI | Outperform |
| 2020-11-10 | 開始されました | Piper Sandler | Overweight |
すべてを表示
Praxis Precision Medicines Inc (PRAX) 最新ニュース
Praxis Precision Medicines (PRAX) reports $926M 2025 cash balance, extended runway - MSN
(PRAX) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Biotech Stock Up 685% Draws $80.5 Million Investment Amid Dual FDA Filings - AOL.com
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter - AOL.com
Aug Swings: Is Praxis Precision Medicines Inc forming bullish engulfing patterns2026 Reactions & Reliable Momentum Entry Alerts - baoquankhu1.vn
Praxis Stock Has Surged 700% in a Year, and This Fund Is Betting $266 Million on Its Pipeline - AOL.com
5AM Venture Divests Entire Praxis Precision Medicines Position | February 2026 FilingNews and Statistics - IndexBox
Biotech Stock Still Up 700% Despite 30% Drop This Year as One Fund Discloses $9 Million Exit - Yahoo Finance
Will Extended Cash Runway And Dual FDA Filings Shift Praxis Precision Medicines' (PRAX) Narrative Toward Commercialization? - Yahoo Finance
Praxis Precision Medicines (PRAX) Reports $926M 2025 Cash Balance, Extended Runway - Insider Monkey
PRAX PE Ratio & Valuation, Is PRAX Overvalued - Intellectia AI
Praxis Stock Surges 320% as One Biotech Investor's Buy Pushes Stake to Nearly $600 Million - AOL.com
Algert Global LLC Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Cormorant Sells $9.31M in Praxis Shares, Holding Remains Top Position | 2026 UpdateNews and Statistics - IndexBox
This biotech stock, which has surged by 700%, remains one of the leading holdings even after a $9.3 million sale in the previous quarter. - Bitget
This Biotech Stock Up 700% Is Still a Top Holding Despite a $9.3 Million Sale Last Quarter - The Motley Fool
HighVista Strategies LLC Has $5.04 Million Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines (PRAX) Is Down 5.4% After Major Institutional Buying and FDA FilingsHas The Bull Case Changed? - simplywall.st
Is Praxis Precision Medicines (PRAX) Still Attractive After Its Big Share Price Run? - Yahoo Finance
Praxis FDA Filings Shift Focus From Pipeline Promise To Potential Revenue - Yahoo Finance
PRAX Technical Analysis & Stock Price Forecast - Intellectia AI
Praxis Precision Medicines, Inc. $PRAX Shares Sold by B Group Inc. - MarketBeat
Investor Buys Up $81 Million in Praxis Stock as Shares Soar Over 300% in One Year - AOL.com
A Look At Praxis Precision Medicines (PRAX) Valuation After New Driehaus Investment And Recent FDA Filings - simplywall.st
Analysts Offer Insights on Healthcare Companies: Praxis Precision Medicines (PRAX), Biohaven Ltd. (BHVN) and Siemens Healthineers AG (OtherSEMHF) - The Globe and Mail
Liquidity Mapping Around (PRAX) Price Events - Stock Traders Daily
Analysts Offer Insights on Healthcare Companies: ARS Pharmaceuticals (SPRY), BillionToOne, Inc. Class A (BLLN) and Praxis Precision Medicines (PRAX) - The Globe and Mail
BTIG Maintains Buy on Praxis Precision Medicines (PRAX) March 2026 - Meyka
BTIG reiterates Buy on Praxis Precision Medicines stock at $843 By Investing.com - Investing.com Canada
BTIG reiterates Buy on Praxis Precision Medicines stock at $843 - Investing.com
Vanguard Group Inc. Increases Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Knott David M Jr Invests $1.48 Million in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines Stock Drops After Culper Research Reveals Short Position - MSN
Praxis Precision Medicines, Inc. $PRAX Shares Bought by Rafferty Asset Management LLC - MarketBeat
Praxis Precision Medicines, Inc. $PRAX Shares Sold by TD Asset Management Inc - MarketBeat
Praxis Precision Medicines, Inc. (NASDAQ:PRAX) Receives Average Recommendation of "Moderate Buy" from Analysts - MarketBeat
A Look At Praxis Precision Medicines (PRAX) Valuation After Wider Full Year And Q4 Net Loss - simplywall.st
Praxis Precision Medicines, Inc. Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Biotech Praxis gives 2,931 stock units to 14 new employees - Stock Titan
PRAX Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
Praxis Eyes Blockbuster Future As Precision Neurology Pipeline Matures - Citeline News & Insights
Why (PRAX) Price Action Is Critical for Tactical Trading - Stock Traders Daily
GSA Capital Partners LLP Trims Stock Position in Praxis Precision Medicines, Inc. $PRAX - MarketBeat
Praxis Precision Medicines Inc (PRAX) 財務データ
収益
当期純利益
現金流量
EPS
1.82%
大文字化:
|
ボリューム (24 時間):